October 28, 2021
Sumitomo Dainippon Pharma said on October 27 that it saw its first-half revenue rise 12.3% year on year, primarily driven by an upfront payment it earned through the company’s alliance deal with Otsuka Pharmaceutical in the area of CNS. In...read more